Tag Archives: diabetes

September, 2018

August, 2018

June, 2018

April, 2018

December, 2017

  • 22 December

    FDA Approves Merck and Pfizer’s SGLT2 Drug for Treatment of Type 2 Diabetes

    KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:PFE), today announced that the U.S. Food and Drug Administration (FDA) has approved STEGLATROTM(ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN™ (ertugliflozin and sitagliptin) tablets. …

  • 13 December

    FDA Approves Sanofi’s Admelog, a Biosimilar of Humalog

    PARIS, Dec. 11, 2017 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Admelog®, the first follow-on insulin lispro to help people living with diabetes manage blood sugar levels at mealtime. “Sanofi has a deep heritage and broad experience in providing treatments for people living with diabetes. Complementing our existing insulin …

November, 2017

July, 2017